[Federal Register Volume 90, Number 109 (Monday, June 9, 2025)]
[Notices]
[Pages 24278-24279]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-10432]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2025-0024]
Meeting of the Advisory Committee on Immunization Practices
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public. Time will be available for
public comment.
DATES: The meeting will be held on June 25, 2025, from 8 a.m. to 5
p.m., EDT, June 26, 2025, from 8 a.m. to 5 p.m., EDT, and June 27,
2025, 8 a.m. to 3 p.m., EDT (times subject to change; see the ACIP
website for updates: https://www.cdc.gov/vaccines/acip/index.html.
Written comments must be received between June 9-20, 2025.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2025-
0024, by either of the methods listed below. CDC does not accept
comments by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Ms. Stephanie Thomas, ACIP Meeting, Centers for
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8,
Atlanta, Georgia 30329-4027. Attn: Docket No. CDC-2025-0024.
Instructions: All submissions received must include the Agency name
and docket number. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the ACIP website at https://www.cdc.gov/acip.
FOR FURTHER INFORMATION CONTACT: Ms. Stephanie Thomas, Committee
Management Specialist, Advisory Committee on Immunization Practices,
National Center for Immunization and Respiratory Diseases, Centers for
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8,
Atlanta, Georgia 30329-4027. Telephone: (404) 639-8836; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee on Immunization Practices is
charged with advising the Director, Centers for Disease Control and
Prevention (CDC), on the use of immunizing agents. In addition, under
42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children program, along with schedules regarding dosing interval,
dosage, and contraindications to administration of vaccines. Further,
under applicable provisions of the Affordable Care Act and section 2713
of the Public Health Service Act, immunization recommendations of ACIP
that have been adopted by the Director, CDC, and appear on CDC
immunization schedules generally must be covered by applicable health
plans.
Matters To Be Considered: The agenda will include discussions on
anthrax vaccines, chikungunya vaccines, COVID-19 vaccines,
cytomegalovirus (CMV) vaccine, Human papillomavirus (HPV) vaccine,
influenza vaccines, Lyme disease vaccine, meningococcal vaccines,
pneumococcal vaccines, Respiratory Syncytial Virus (RSV) vaccines for
adults, and RSV vaccines for maternal and pediatric populations.
Recommendation votes are scheduled for COVID-19 vaccines, HPV vaccine,
influenza vaccines, meningococcal vaccine, RSV vaccines for adults, and
RSV vaccine for maternal and pediatric populations. Vaccines for
Children (VFC) votes are scheduled for COVID-19 vaccines, HPV vaccine,
influenza vaccines, and RSV vaccines. Agenda items are subject to
change as priorities dictate. For more information on the meeting
agenda, visit https://www.cdc.gov/acip/meetings/index.html.
Meeting Information: The meeting will be webcast live via the World
Wide Web. For more information on ACIP, please visit the ACIP website:
https://www.cdc.gov/acip.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and
[[Page 24279]]
other supporting materials, are part of the public record and are
subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your
comment or supporting materials that you consider confidential or
inappropriate for public disclosure. If you include your name, contact
information, or other information that identifies you in the body of
your comments, that information will be on public display. CDC will
review all submissions and may choose to redact, or withhold,
submissions containing private or proprietary information such as
Social Security numbers, medical information, inappropriate language,
or duplicate/near-duplicate examples of a mass-mail campaign. CDC will
carefully consider all comments submitted into the docket.
Written Public Comment: The docket will be opened to receive
written comments June 9-20, 2025. Written comments must be received by
June 20, 2025.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes, including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the June 25-27, 2025, ACIP meeting must
submit a request at https://www.cdc.gov/acip/meetings/index.html
between June 9-20, 2025, and no later than 11:59 p.m., EDT, June 20,
2025, according to the instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
random draw to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by June 23, 2025. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to three minutes, and each
speaker may speak only once per meeting.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2025-10432 Filed 6-6-25; 8:45 am]
BILLING CODE 4163-18-P